Informatie:
Fout:
ID
23205
Beschrijving
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00527514
Link
https://clinicaltrials.gov/show/NCT00527514
Trefwoorden
Versies (1)
- 28-06-17 28-06-17 -
Geüploaded op
28 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hypertension NCT00527514
Eligibility Hypertension NCT00527514
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00527514
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
males or females greater than or equal to 18 years of age
boolean
C0001779 (UMLS CUI [1])
ID.2
Item
patients with a mean seated systolic blood pressure (mssbp) greater than or equal to 140 mm hg but less than or equal to 199 mm hg or a mean seated diastolic blood pressure (msdbp) greater than or equal to 90 mm hg and less than or equal to 109 mm hg, following a period of taking only placebo
boolean
C0005823 (UMLS CUI [1,1])
C0420256 (UMLS CUI [1,2])
C0420256 (UMLS CUI [1,2])
ID.3
Item
patients with a mean daytime (8am-4pm) systolic blood pressure greater than or equal to 135 mm hg and less than or equal to 199 mm hg and a mean daytime diastolic blood pressure less than or equal to 109 mm hg as measured by an ambulatory blood pressure monitoring device (abpm), after a period of taking only placebo
boolean
C0005823 (UMLS CUI [1,1])
C0420256 (UMLS CUI [1,2])
C0420256 (UMLS CUI [1,2])
ID.4
Item
if female, must have negative serum pregnancy test at screening and be either post-menopausal (greater than or equal to 1 year), had a hysterectomy or tubal ligation at least 6 months before consent or if of childbearing potential, must practice approved measures of birth control throughout study
boolean
C0032961 (UMLS CUI [1,1])
C0009862 (UMLS CUI [1,2])
C0232970 (UMLS CUI [1,3])
C0009862 (UMLS CUI [1,2])
C0232970 (UMLS CUI [1,3])
ID.5
Item
history of stroke or transient ischemic attack (tia) within the last one year
boolean
C0038454 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
C0007787 (UMLS CUI [1,2])
ID.6
Item
history of myocardial infarction, coronary angioplasty, coronary artery bypass graft, or heart failure within the past 6 months
boolean
C0027051 (UMLS CUI [1,1])
C0190211 (UMLS CUI [1,2])
C0396750 (UMLS CUI [1,3])
C0018801 (UMLS CUI [1,4])
C0190211 (UMLS CUI [1,2])
C0396750 (UMLS CUI [1,3])
C0018801 (UMLS CUI [1,4])
ID.7
Item
patients with secondary hypertension of any etiology, such as renal disease, pheochromocytoma, or cushing's syndrome
boolean
C0155616 (UMLS CUI [1])
ID.8
Item
type i diabetes. patients with type ii diabetes on stable treatment, with fasting glucose <160 mg/dl may enroll
boolean
C0011854 (UMLS CUI [1])
ID.9
Item
patients with hemodynamically significant cardiac valvular disease
boolean
C0018824 (UMLS CUI [1,1])
C0948268 (UMLS CUI [1,2])
C0948268 (UMLS CUI [1,2])
ID.10
Item
patients with clinically significant cardiac conduction defects, including second or third degree av block, left bundle branch block, sick sinus syndrome, atrial fibrillation, atrial flutter, an accessory bypass tract, or any arrhythmia requiring medication
boolean
C0018799 (UMLS CUI [1])